Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Dynamics of the mitotic spindle--potential therapeutic targets.

Miyamoto DT, Perlman ZE, Mitchison TJ, Shirasu-Hiza M.

Prog Cell Cycle Res. 2003;5:349-60. Review.

PMID:
14593729
2.

Coupling cell division and cell death to microtubule dynamics.

Sorger PK, Dobles M, Tournebize R, Hyman AA.

Curr Opin Cell Biol. 1997 Dec;9(6):807-14. Review.

PMID:
9425345
3.

Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators.

Wilson L, Panda D, Jordan MA.

Cell Struct Funct. 1999 Oct;24(5):329-35. Review.

4.

Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents.

Dowling M, Voong KR, Kim M, Keutmann MK, Harris E, Kao GD.

Cancer Biol Ther. 2005 Feb;4(2):197-206. Epub 2005 Feb 8.

PMID:
15753652
5.

Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation.

Mohan R, Banerjee M, Ray A, Manna T, Wilson L, Owa T, Bhattacharyya B, Panda D.

Biochemistry. 2006 May 2;45(17):5440-9. Erratum in: Biochemistry. 2006 Aug 1;45(30):9362.

PMID:
16634625
6.

The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics.

Okouneva T, Hill BT, Wilson L, Jordan MA.

Mol Cancer Ther. 2003 May;2(5):427-36.

7.

The spindle: a dynamic assembly of microtubules and motors.

Wittmann T, Hyman A, Desai A.

Nat Cell Biol. 2001 Jan;3(1):E28-34. Review.

PMID:
11146647
8.

Microtubule motors in mitosis.

Sharp DJ, Rogers GC, Scholey JM.

Nature. 2000 Sep 7;407(6800):41-7. Review.

PMID:
10993066
9.

Mitotic microtubule crosslinkers: insights from mechanistic studies.

Peterman EJ, Scholey JM.

Curr Biol. 2009 Dec 15;19(23):R1089-94. doi: 10.1016/j.cub.2009.10.047. Review.

10.

2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules.

Kamath K, Okouneva T, Larson G, Panda D, Wilson L, Jordan MA.

Mol Cancer Ther. 2006 Sep;5(9):2225-33.

11.

Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy.

Mistry SJ, Atweh GF.

Mt Sinai J Med. 2002 Oct;69(5):299-304. Review.

PMID:
12415323
12.
13.

Cell division: running rings around the spindle.

Nath D.

Nature. 2006 Mar 23;440(7083):434. No abstract available.

PMID:
16554798
14.

The kinetochore and spindle checkpoint in mammals.

Kops GJ.

Front Biosci. 2008 May 1;13:3606-20. Review.

PMID:
18508459
15.

Microtubule-associated proteins as targets in cancer chemotherapy.

Bhat KM, Setaluri V.

Clin Cancer Res. 2007 May 15;13(10):2849-54. Review.

16.

Probing cell-division phenotype space and Polo-like kinase function using small molecules.

Peters U, Cherian J, Kim JH, Kwok BH, Kapoor TM.

Nat Chem Biol. 2006 Nov;2(11):618-26. Epub 2006 Oct 8.

PMID:
17028580
17.

Assessment of the mitotic spindle assembly checkpoint (SAC) as the target of anticancer therapies.

Bolanos-Garcia VM.

Curr Cancer Drug Targets. 2009 Mar;9(2):131-41. Review.

PMID:
19275754
18.

Return of the matrix.

Travis J.

Science. 2007 Nov 30;318(5855):1400-1. No abstract available.

PMID:
18048678
19.

Microtubules as a target for anticancer drugs.

Jordan MA, Wilson L.

Nat Rev Cancer. 2004 Apr;4(4):253-65. Review. No abstract available.

PMID:
15057285
20.

Supplemental Content

Support Center